ArticleBMC health services research2009
The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain.
Article in BMC health services research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.
- An international compendium of health state utilities in people with HIV: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Pooled it
- Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies.BMC health services research · 2021Pooled it
- Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis.BMC health services research · 2015Pooled it
- Economic burden and health-related quality of life in patients with epidermolysis bullosa in Spain.Orphanet journal of rare diseases · 2024Article
- Determinants and economic burden of HIV/AIDS in Iran: a prospective study.BMC health services research · 2023Article
- Determinants of Depressive Symptoms in People Living with HIV: Findings from a Population-Based Study with a Gender Perspective.International journal of environmental research and public health · 2023Article
- Health-Related Quality of Life, Pain and Sleep in Patients with HIV Depending on the Clinical Situation: A Cross-Sectional Pilot Study.Tropical medicine and infectious disease · 2022Article
- Health-Related Quality of Life of HIV-Positive and HIV-Negative Pregnant Women in an Impoverished Area: Cross-sectional Study.JMIR public health and surveillance · 2022Article
- Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.Orphanet journal of rare diseases · 2021Article
- Under-documentation of psychiatric diagnoses among persons living with HIV in electronic medical records.AIDS care · 2021Article
- Economic burden and mental health of primary caregivers of perinatally HIV infected adolescents from Kilifi, Kenya.BMC public health · 2020Article
- Nurturing Practitioner-Researcher Partnerships to Improve Adoption and Delivery of Research-Based Social and Public Health Services Worldwide.International journal of environmental research and public health · 2019Article
- Cost-utility and budget impact of methylene blue-treated plasma compared to quarantine plasma.Blood transfusion = Trasfusione del sangue · 2018Article
- Social economic costs of COPD in Extremadura (Spain): an observational study.International journal of chronic obstructive pulmonary disease · 2018Observational
- The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.BMC health services research · 2017Article
- Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2016Article
- Social/economic costs and health-related quality of life in patients with scleroderma in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2016Article
- Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2016Article
- HIV practitioners in Madrid and New York improving inclusion of underrepresented populations in research.Health promotion international · 2015Article
- Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study.BMC health services research · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe objective was to determine the economic burden, as well as the impact on HRQOL for people with HIV/AIDS in Spain in 2003.
methodsA cross-sectional study of 572 people with HIV were recruited from outpatient clinics in the Canary Islands, Spain. Demographic, health resources utilization, indirect costs and quality of life data were collected through medical records and questionnaires filled out by people with HIV. HRQOL was measured with two generic questionnaires: SF-36 and EQ-5D.
resultsIn 2003 annual costs of caring for patients with asymptomatic HIV, symptomatic HIV and AIDS were euro10,351, euro14,489 and euro15,750, respectively. The HRQOL with the EQ-5D was 0.78. SF-36 summary results for physical and mental health were 48.30 and 38.80, respectively.
conclusionHIV/AIDS represent a high economic impact from society point of view. the structure of health care costs have changed due to these new drugs, increasing the weight of pharmaceutical treatment over total costs and decreasing the importance of inpatient care costs. In spite of the therapeutic improvements, labour losses/indirect costs still represent a high cost. Costs and HRQOL were strongly associated with severity. Although the latest drug developments have not yet been able to find the definitive cure, they have allowed an improvement in expectancy of life and in the HRQOL of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.